Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure.

Item

http://www.wikidata.org/entity/Q50923400

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Impact of salvage regimens on ...... ukemia with induction failure.

@en

Impact of salvage regimens on ...... ukemia with induction failure.

@nl

type

Item

label

Impact of salvage regimens on ...... ukemia with induction failure.

@en

Impact of salvage regimens on ...... ukemia with induction failure.

@nl

prefLabel

Impact of salvage regimens on ...... ukemia with induction failure.

@en

Impact of salvage regimens on ...... ukemia with induction failure.

@nl

P1476

Impact of salvage regimens on ...... ukemia with induction failure.

@en

P2093

A Benner

http://www.w3.org/2001/XMLSchema#string

A Ganser

http://www.w3.org/2001/XMLSchema#string

A Kündgen

http://www.w3.org/2001/XMLSchema#string

C-H Köhne

http://www.w3.org/2001/XMLSchema#string

D Nachbaur

http://www.w3.org/2001/XMLSchema#string

D Weber

http://www.w3.org/2001/XMLSchema#string

F Thol

http://www.w3.org/2001/XMLSchema#string

G Held

http://www.w3.org/2001/XMLSchema#string

G Wulf

http://www.w3.org/2001/XMLSchema#string

H Döhner

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.

The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: ...

The World Health Organization (WHO) classification of the myeloid neoplasms

Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials.

A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blas

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

P2888

leu.2017.23

P304

1306-1313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2017.23

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28138160

http://www.w3.org/2001/XMLSchema#string